You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
科倫藥業(002422.SZ):基於對公司價值高度認可 控股股東提議公司回購1億元-2億元的股份
格隆匯 12-04 20:12

格隆匯12月4日丨科倫藥業(002422.SZ)公佈,公司於2019年12月4日收到了公司控股股東劉革新《關於提議四川科倫藥業股份有限公司回購股份的函》。

劉革新基於對公司價值的高度認可和對公司未來發展前景的信心,考慮到公司股票的持續低迷,為增強投資者對公司的信心;同時也為建立健全公司長效激勵約束機制,有效提升核心團隊凝聚力和企業核心競爭力,將股東、公司和核心團隊三方利益結合在一起,使各方共同關注公司的長遠發展,確保公司發展戰略和經營目標的實現,特提議公司以自有資金通過集中競價交易方式進行股份回購。

結合近期公司股價,此次擬回購價格上限不超過25元/股,回購總金額1億元-2億元人民幣。在回購股份價格不超過人民幣25元/股的條件下,按回購金額上限測算,預計回購股份數量約800萬股,約佔公司當前總股本的0.56%;按回購金額下限測算,預計回購股份數量約400萬股,約佔公司當前總股本的0.28%。具體回購股份的金額以回購期限屆滿時實際回購的金額為準。

此次回購的股份將用作員工持股或股權激勵計劃。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account